 Fredrick Rosario-Joseph
Concepts (260)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Trophoblasts | 21 | 2026 | 216 | 7.810 |
Why?
| | Placenta | 34 | 2026 | 780 | 6.340 |
Why?
| | TOR Serine-Threonine Kinases | 27 | 2026 | 449 | 5.600 |
Why?
| | Fetal Development | 13 | 2026 | 299 | 3.320 |
Why?
| | Amino Acid Transport System A | 6 | 2025 | 37 | 2.640 |
Why?
| | Mechanistic Target of Rapamycin Complex 1 | 12 | 2025 | 139 | 2.470 |
Why?
| | Fetal Growth Retardation | 13 | 2025 | 587 | 2.410 |
Why?
| | Folic Acid | 7 | 2025 | 199 | 2.240 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 8 | 2023 | 63 | 2.200 |
Why?
| | Amino Acid Transport System L | 3 | 2025 | 19 | 1.950 |
Why?
| | Pregnancy | 48 | 2026 | 7190 | 1.670 |
Why?
| | Diabetes, Gestational | 6 | 2023 | 321 | 1.660 |
Why?
| | Amino Acids | 6 | 2026 | 521 | 1.650 |
Why?
| | Intracellular Signaling Peptides and Proteins | 6 | 2025 | 459 | 1.600 |
Why?
| | Glucose Intolerance | 5 | 2022 | 142 | 1.440 |
Why?
| | Fusion Regulatory Protein 1, Light Chains | 2 | 2026 | 9 | 1.410 |
Why?
| | Adiponectin | 9 | 2025 | 244 | 1.330 |
Why?
| | Receptors, Adiponectin | 3 | 2025 | 22 | 1.230 |
Why?
| | Insulin-Like Growth Factor I | 7 | 2026 | 319 | 1.220 |
Why?
| | Folic Acid Deficiency | 3 | 2021 | 49 | 1.180 |
Why?
| | Amino Acid Transport Systems | 5 | 2017 | 43 | 1.160 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 2 | 2026 | 17 | 1.150 |
Why?
| | Signal Transduction | 20 | 2026 | 5226 | 1.030 |
Why?
| | Multiprotein Complexes | 5 | 2025 | 172 | 1.030 |
Why?
| | Insulin | 11 | 2026 | 2507 | 1.020 |
Why?
| | Fetal Weight | 4 | 2015 | 54 | 1.010 |
Why?
| | Transposases | 1 | 2025 | 19 | 0.910 |
Why?
| | Maternal Nutritional Physiological Phenomena | 6 | 2021 | 181 | 0.820 |
Why?
| | Insulin Resistance | 6 | 2022 | 1241 | 0.790 |
Why?
| | Gene Expression Regulation, Developmental | 3 | 2021 | 905 | 0.770 |
Why?
| | Maternal-Fetal Exchange | 3 | 2021 | 169 | 0.770 |
Why?
| | Obesity | 12 | 2023 | 3077 | 0.760 |
Why?
| | Cell Membrane | 6 | 2020 | 706 | 0.760 |
Why?
| | Liver | 4 | 2026 | 1887 | 0.720 |
Why?
| | RNA Interference | 6 | 2021 | 476 | 0.720 |
Why?
| | Diet, Protein-Restricted | 1 | 2021 | 11 | 0.700 |
Why?
| | Gene Knockdown Techniques | 4 | 2025 | 336 | 0.670 |
Why?
| | Mitochondria | 2 | 2025 | 984 | 0.670 |
Why?
| | Folate Receptor 1 | 2 | 2019 | 17 | 0.640 |
Why?
| | Biological Transport | 5 | 2025 | 417 | 0.630 |
Why?
| | Animals | 38 | 2026 | 38058 | 0.630 |
Why?
| | Mice | 20 | 2026 | 18339 | 0.630 |
Why?
| | cdc42 GTP-Binding Protein | 1 | 2020 | 22 | 0.630 |
Why?
| | Female | 53 | 2026 | 78271 | 0.620 |
Why?
| | rac1 GTP-Binding Protein | 1 | 2020 | 56 | 0.610 |
Why?
| | Transfection | 3 | 2024 | 940 | 0.590 |
Why?
| | Placental Insufficiency | 1 | 2019 | 125 | 0.520 |
Why?
| | Fetal Macrosomia | 4 | 2023 | 62 | 0.520 |
Why?
| | Pregnancy Complications | 7 | 2019 | 592 | 0.510 |
Why?
| | Leptin | 2 | 2015 | 245 | 0.510 |
Why?
| | Papio | 6 | 2021 | 85 | 0.490 |
Why?
| | Endosomal Sorting Complexes Required for Transport | 2 | 2015 | 46 | 0.490 |
Why?
| | Regulatory-Associated Protein of mTOR | 4 | 2019 | 24 | 0.480 |
Why?
| | Fetal Nutrition Disorders | 1 | 2015 | 7 | 0.470 |
Why?
| | Adaptor Proteins, Signal Transducing | 2 | 2015 | 427 | 0.450 |
Why?
| | Ubiquitin-Protein Ligases | 2 | 2015 | 192 | 0.440 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2022 | 675 | 0.430 |
Why?
| | Weight Gain | 2 | 2015 | 556 | 0.410 |
Why?
| | Fatty Liver | 2 | 2022 | 251 | 0.400 |
Why?
| | Cells, Cultured | 7 | 2020 | 4154 | 0.390 |
Why?
| | Placentation | 3 | 2021 | 53 | 0.390 |
Why?
| | Nutritional Status | 1 | 2015 | 354 | 0.380 |
Why?
| | Down-Regulation | 4 | 2017 | 627 | 0.370 |
Why?
| | Rapamycin-Insensitive Companion of mTOR Protein | 3 | 2019 | 27 | 0.370 |
Why?
| | Gene Targeting | 1 | 2012 | 82 | 0.370 |
Why?
| | Mice, Transgenic | 3 | 2025 | 2182 | 0.350 |
Why?
| | Mice, Obese | 4 | 2022 | 66 | 0.350 |
Why?
| | Oxidative Phosphorylation | 2 | 2025 | 210 | 0.350 |
Why?
| | Primary Cell Culture | 3 | 2019 | 173 | 0.340 |
Why?
| | Lentivirus | 2 | 2025 | 60 | 0.310 |
Why?
| | Dietary Proteins | 1 | 2011 | 136 | 0.310 |
Why?
| | Phosphorylation | 4 | 2023 | 1732 | 0.300 |
Why?
| | Insulin-Like Growth Factor Binding Protein 1 | 2 | 2023 | 25 | 0.300 |
Why?
| | STAT3 Transcription Factor | 1 | 2011 | 207 | 0.290 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenases | 1 | 2008 | 3 | 0.290 |
Why?
| | Autophagy | 2 | 2024 | 286 | 0.290 |
Why?
| | Proton-Coupled Folate Transporter | 2 | 2019 | 9 | 0.290 |
Why?
| | Vitamin E Deficiency | 1 | 2008 | 42 | 0.290 |
Why?
| | Extracellular Vesicles | 2 | 2022 | 171 | 0.290 |
Why?
| | Nedd4 Ubiquitin Protein Ligases | 3 | 2016 | 15 | 0.270 |
Why?
| | Copper | 1 | 2008 | 113 | 0.270 |
Why?
| | Micronutrients | 1 | 2008 | 96 | 0.270 |
Why?
| | Glucose | 4 | 2022 | 1047 | 0.270 |
Why?
| | Gestational Age | 4 | 2021 | 975 | 0.270 |
Why?
| | Heart Diseases | 2 | 2022 | 349 | 0.260 |
Why?
| | Malaria, Falciparum | 2 | 2017 | 33 | 0.260 |
Why?
| | Humans | 32 | 2025 | 144759 | 0.250 |
Why?
| | Folic Acid Transporters | 1 | 2025 | 3 | 0.240 |
Why?
| | Disease Models, Animal | 6 | 2022 | 4557 | 0.240 |
Why?
| | Mice, Inbred C57BL | 8 | 2024 | 5992 | 0.230 |
Why?
| | Cell Respiration | 1 | 2025 | 107 | 0.230 |
Why?
| | Zinc | 1 | 2008 | 295 | 0.230 |
Why?
| | Biological Availability | 2 | 2023 | 142 | 0.220 |
Why?
| | Serotonin | 2 | 2020 | 293 | 0.220 |
Why?
| | Claudin-4 | 1 | 2024 | 17 | 0.210 |
Why?
| | Amino Acids, Essential | 1 | 2023 | 13 | 0.200 |
Why?
| | Genomic Instability | 1 | 2024 | 66 | 0.200 |
Why?
| | Gene Transfer Techniques | 1 | 2024 | 185 | 0.190 |
Why?
| | Blood Glucose | 5 | 2022 | 2327 | 0.190 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2608 | 0.190 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2022 | 190 | 0.190 |
Why?
| | Membrane Transport Proteins | 1 | 2023 | 154 | 0.190 |
Why?
| | Ubiquitination | 3 | 2022 | 118 | 0.180 |
Why?
| | Overnutrition | 1 | 2022 | 30 | 0.180 |
Why?
| | N-Acetylglucosaminyltransferases | 1 | 2020 | 24 | 0.160 |
Why?
| | Organogenesis | 1 | 2021 | 65 | 0.160 |
Why?
| | Embryo, Mammalian | 1 | 2021 | 232 | 0.160 |
Why?
| | Embryonic Development | 1 | 2021 | 125 | 0.160 |
Why?
| | Carrier Proteins | 3 | 2017 | 737 | 0.160 |
Why?
| | RNA, Small Interfering | 2 | 2012 | 635 | 0.160 |
Why?
| | Reduced Folate Carrier Protein | 1 | 2019 | 9 | 0.160 |
Why?
| | Hypertension | 1 | 2008 | 1263 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2022 | 436 | 0.150 |
Why?
| | Organelle Biogenesis | 1 | 2019 | 15 | 0.150 |
Why?
| | Electron Transport | 1 | 2019 | 118 | 0.140 |
Why?
| | Gene Silencing | 2 | 2016 | 205 | 0.140 |
Why?
| | Ovarian Neoplasms | 1 | 2024 | 586 | 0.140 |
Why?
| | Lysosomal-Associated Membrane Protein 2 | 1 | 2017 | 32 | 0.130 |
Why?
| | Metabolic Diseases | 1 | 2018 | 114 | 0.130 |
Why?
| | Protein Transport | 2 | 2015 | 441 | 0.130 |
Why?
| | Mice, Inbred ICR | 1 | 2017 | 113 | 0.130 |
Why?
| | Docosahexaenoic Acids | 1 | 2017 | 83 | 0.130 |
Why?
| | Pregnancy Complications, Parasitic | 1 | 2017 | 9 | 0.130 |
Why?
| | Homocysteine | 1 | 2017 | 151 | 0.120 |
Why?
| | Food Deprivation | 1 | 2016 | 27 | 0.120 |
Why?
| | Maternal Age | 1 | 2016 | 126 | 0.120 |
Why?
| | Amino Acid Transport System y+L | 1 | 2015 | 4 | 0.120 |
Why?
| | PPAR alpha | 2 | 2015 | 54 | 0.120 |
Why?
| | Homeostasis | 1 | 2020 | 640 | 0.120 |
Why?
| | Animal Nutritional Physiological Phenomena | 1 | 2015 | 14 | 0.120 |
Why?
| | Fatty Acid Transport Proteins | 1 | 2015 | 22 | 0.120 |
Why?
| | Up-Regulation | 2 | 2015 | 851 | 0.110 |
Why?
| | Prenatal Nutritional Physiological Phenomena | 1 | 2015 | 59 | 0.110 |
Why?
| | Placental Circulation | 1 | 2015 | 70 | 0.110 |
Why?
| | Fatty Acid-Binding Proteins | 1 | 2015 | 79 | 0.110 |
Why?
| | Diet, High-Fat | 2 | 2022 | 261 | 0.110 |
Why?
| | Casein Kinase II | 1 | 2014 | 22 | 0.100 |
Why?
| | Enzyme Activation | 1 | 2015 | 766 | 0.100 |
Why?
| | Caloric Restriction | 1 | 2015 | 127 | 0.100 |
Why?
| | Fatty Acids | 2 | 2022 | 450 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 576 | 0.100 |
Why?
| | Pregnancy Complications, Infectious | 1 | 2017 | 428 | 0.100 |
Why?
| | Peroxisome Proliferator-Activated Receptors | 1 | 2022 | 17 | 0.090 |
Why?
| | Inflammation Mediators | 1 | 2015 | 509 | 0.090 |
Why?
| | Leucine | 1 | 2012 | 116 | 0.090 |
Why?
| | Lipid Metabolism | 1 | 2015 | 527 | 0.090 |
Why?
| | Dependovirus | 1 | 2012 | 79 | 0.090 |
Why?
| | Adult | 7 | 2022 | 40449 | 0.080 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2011 | 24 | 0.080 |
Why?
| | DNA Methylation | 1 | 2016 | 681 | 0.080 |
Why?
| | Embryo Implantation | 2 | 2001 | 30 | 0.080 |
Why?
| | Endometrium | 2 | 2001 | 61 | 0.080 |
Why?
| | Male | 11 | 2022 | 72315 | 0.080 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2022 | 380 | 0.080 |
Why?
| | Cardiovascular Diseases | 1 | 2022 | 2168 | 0.080 |
Why?
| | Rats | 3 | 2021 | 5597 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2015 | 935 | 0.070 |
Why?
| | Young Adult | 4 | 2019 | 14105 | 0.070 |
Why?
| | Mothers | 1 | 2015 | 775 | 0.070 |
Why?
| | Phosphoproteins | 1 | 2011 | 344 | 0.070 |
Why?
| | Proteolysis | 2 | 2022 | 173 | 0.070 |
Why?
| | Systole | 1 | 2008 | 178 | 0.070 |
Why?
| | PPAR gamma | 2 | 2022 | 176 | 0.070 |
Why?
| | Body Weight | 1 | 2012 | 976 | 0.070 |
Why?
| | Boswellia | 1 | 2007 | 1 | 0.060 |
Why?
| | Reproduction | 1 | 2008 | 207 | 0.060 |
Why?
| | MicroRNAs | 1 | 2012 | 701 | 0.060 |
Why?
| | Infant, Newborn | 4 | 2022 | 6429 | 0.060 |
Why?
| | Transcriptome | 1 | 2022 | 1045 | 0.060 |
Why?
| | Diabetes Mellitus, Experimental | 1 | 2007 | 198 | 0.060 |
Why?
| | Plant Extracts | 1 | 2007 | 187 | 0.060 |
Why?
| | Lipids | 2 | 2022 | 710 | 0.060 |
Why?
| | Micronuclei, Chromosome-Defective | 1 | 2024 | 8 | 0.050 |
Why?
| | Amino Acid Transport System ASC | 1 | 2024 | 12 | 0.050 |
Why?
| | Rats, Wistar | 2 | 2021 | 451 | 0.050 |
Why?
| | Minor Histocompatibility Antigens | 1 | 2024 | 47 | 0.050 |
Why?
| | Diet | 1 | 2011 | 1273 | 0.050 |
Why?
| | Angiogenesis Inhibitors | 2 | 2001 | 237 | 0.050 |
Why?
| | Adult Children | 1 | 2022 | 26 | 0.050 |
Why?
| | 3T3-L1 Cells | 1 | 2022 | 36 | 0.040 |
Why?
| | Muscle, Skeletal | 1 | 2022 | 1795 | 0.040 |
Why?
| | Glucagon-Like Peptide 1 | 1 | 2023 | 146 | 0.040 |
Why?
| | Carnitine | 1 | 2022 | 90 | 0.040 |
Why?
| | Fetal Heart | 1 | 2022 | 57 | 0.040 |
Why?
| | Birth Weight | 2 | 2017 | 522 | 0.040 |
Why?
| | Glucose Tolerance Test | 1 | 2022 | 361 | 0.040 |
Why?
| | Monoamine Oxidase | 1 | 2020 | 25 | 0.040 |
Why?
| | Case-Control Studies | 2 | 2021 | 3604 | 0.040 |
Why?
| | Intra-Abdominal Fat | 1 | 2022 | 100 | 0.040 |
Why?
| | Cardiomegaly | 1 | 2022 | 174 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2001 | 98 | 0.040 |
Why?
| | Umbilical Cord | 1 | 2020 | 91 | 0.040 |
Why?
| | Adipocytes | 1 | 2022 | 223 | 0.040 |
Why?
| | Microvilli | 1 | 2019 | 75 | 0.040 |
Why?
| | Pregnancy Trimester, Second | 1 | 2019 | 82 | 0.040 |
Why?
| | Pregnancy Trimester, First | 1 | 2019 | 136 | 0.040 |
Why?
| | Microscopy, Electron | 3 | 2007 | 415 | 0.040 |
Why?
| | Anti-Infective Agents | 1 | 2001 | 242 | 0.030 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2024 | 1455 | 0.030 |
Why?
| | Body Mass Index | 2 | 2019 | 2438 | 0.030 |
Why?
| | Phagosomes | 1 | 2017 | 40 | 0.030 |
Why?
| | Cohort Studies | 2 | 2022 | 5960 | 0.030 |
Why?
| | Hormones | 1 | 2017 | 134 | 0.030 |
Why?
| | Lysosomes | 1 | 2017 | 128 | 0.030 |
Why?
| | Blood Platelets | 1 | 2020 | 400 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2007 | 1387 | 0.030 |
Why?
| | Cell Line, Tumor | 1 | 2024 | 3540 | 0.030 |
Why?
| | Fetus | 1 | 2020 | 803 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1539 | 0.030 |
Why?
| | Fatty Acid Binding Protein 3 | 1 | 2015 | 6 | 0.030 |
Why?
| | Echocardiography | 1 | 2019 | 652 | 0.030 |
Why?
| | Infant, Low Birth Weight | 1 | 2017 | 153 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2018 | 902 | 0.030 |
Why?
| | CD36 Antigens | 1 | 2015 | 32 | 0.030 |
Why?
| | Excitatory Amino Acids | 1 | 2015 | 7 | 0.030 |
Why?
| | Biological Transport, Active | 1 | 2015 | 69 | 0.030 |
Why?
| | Transport Vesicles | 1 | 2015 | 21 | 0.030 |
Why?
| | Dietary Sucrose | 1 | 2015 | 49 | 0.030 |
Why?
| | Heart | 1 | 2019 | 636 | 0.030 |
Why?
| | Lipase | 1 | 2015 | 75 | 0.030 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2015 | 120 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2015 | 159 | 0.030 |
Why?
| | Organ Size | 1 | 2015 | 463 | 0.030 |
Why?
| | Hep G2 Cells | 1 | 2014 | 74 | 0.030 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 1 | 2014 | 110 | 0.030 |
Why?
| | Myocardium | 1 | 2019 | 939 | 0.030 |
Why?
| | Receptor, IGF Type 1 | 1 | 2014 | 64 | 0.030 |
Why?
| | Pregnancy, Animal | 1 | 2014 | 52 | 0.030 |
Why?
| | Transgenes | 1 | 2014 | 189 | 0.020 |
Why?
| | Incidence | 1 | 2019 | 2879 | 0.020 |
Why?
| | Hepatocytes | 1 | 2014 | 223 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2014 | 851 | 0.020 |
Why?
| | Administration, Intravaginal | 2 | 2001 | 18 | 0.020 |
Why?
| | Macaca mulatta | 2 | 2001 | 191 | 0.020 |
Why?
| | Cytokines | 1 | 2017 | 2061 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1821 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7990 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2015 | 2832 | 0.020 |
Why?
| | Alloxan | 1 | 2007 | 4 | 0.020 |
Why?
| | Pancreas, Exocrine | 1 | 2007 | 7 | 0.020 |
Why?
| | Glucose-6-Phosphatase | 1 | 2007 | 31 | 0.020 |
Why?
| | Plant Roots | 1 | 2007 | 45 | 0.020 |
Why?
| | Urea | 1 | 2007 | 84 | 0.020 |
Why?
| | Phytotherapy | 1 | 2007 | 74 | 0.020 |
Why?
| | Alkaline Phosphatase | 1 | 2007 | 145 | 0.010 |
Why?
| | Plant Leaves | 1 | 2007 | 137 | 0.010 |
Why?
| | Anticholesteremic Agents | 1 | 2007 | 152 | 0.010 |
Why?
| | Creatinine | 1 | 2007 | 506 | 0.010 |
Why?
| | Cholesterol | 1 | 2007 | 406 | 0.010 |
Why?
| | Epithelial Cells | 2 | 2001 | 1125 | 0.010 |
Why?
| | Triglycerides | 1 | 2007 | 520 | 0.010 |
Why?
| | Endothelium, Vascular | 2 | 2001 | 965 | 0.010 |
Why?
| | Cyclohexanes | 1 | 2001 | 23 | 0.010 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2001 | 86 | 0.010 |
Why?
| | Sesquiterpenes | 1 | 2001 | 52 | 0.010 |
Why?
| | Progesterone | 1 | 2001 | 255 | 0.010 |
Why?
| | Estradiol | 1 | 2001 | 533 | 0.010 |
Why?
| | Time Factors | 1 | 2007 | 7173 | 0.010 |
Why?
| | Peptides | 1 | 2001 | 995 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2007 | 11679 | 0.010 |
Why?
|
|
Rosario-Joseph's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|